To What Extent Should People Have Access to Naloxone?

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, outlines his pros and cons for expanded access to naloxone.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, outlines his pros and cons for expanded access to naloxone.

This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.